Graphite Bio, a startup biotech company, has raised $45 million in an initial financing round to advance its gene…
David Melamed, PhD
David earned a PhD in Biological Sciences from Columbia University in New York, NY, where he studied how Drosophila ovarian adult stem cells respond to cell signaling pathway manipulations. This work helped to redefine the organizational principles underlying adult stem cell growth models. He is currently a Science Writer, as part of the BioNews Services writing team.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by David Melamed, PhD
Emotional distress affected nearly half of the parents caring for adolescents with sickle cell disease in a recent study, with…
Cannabis could be a safe and potentially effective way of easing chronic pain in people with sickle cell disease…
Taking vitamin D supplements may lower the number of visits to the emergency department due to vaso-occlusive pain episodes in…
The U.S. National Institutes of Health (NIH) has awarded researchers at Rice University a four-year, $2.45-million grant to…
The nonprofit HealthWell Foundation launched a new fund to help people with sickle cell disease afford their treatments.
The Sickle Cell Disease Association of America (SCDAA) has announced the extension of its ongoing COVID-19 Emergency Fund…
The supply of the sickle cell disease (SCD) medication Endari (L-glutamine) will not be affected by the…